University of Queensland researchers have reared deadly cone snails in a laboratory aquarium for the first time, uncovering a potential treasure trove of new venoms for drug development. Professor Richard Lewis, Dr Aymeric Rogalski and Dr Himaya Siddhihalu Wickrama Hewage from UQ’s Institute for Molecular Bioscience study venoms as therapeutics, and discovered crucial differences across […]
Oxytocin/vasopressin receptors are typical examples of so-called G protein-coupled receptors – the most successful drug target class. The oxytocin and vasopressin receptors are targeted, for example, during childbirth to encourage contractions but are also being investigated for therapeutic applications in cardiovascular disease, cancer, and developmental disorders such as autism. Inspired by locusts MedUni Vienna researchers […]
Read More… from New drug development using Nature’s strategies
Urgent action needed on BAME workforce risk assessments: According to a new survey from the Royal Pharmaceutical Society (RPS) and the UK Black Pharmacists Association (UKBPA), more than two-thirds of Black, Asian and Minority Ethnic (BAME) pharmacists working in primary care and hospitals still have not yet had potentially lifesaving COVID-19 workplace risk assessments months […]
Read More… from Urgent action needed on BAME workforce risk assessments